Understanding how UBE3A gene mutations affect brain proteins in Angelman Syndrome
Official title: Profiling cell type-specific ubiquitome in UBE3A mutant mice
Funded at University of Wisconsin-Madison · NIH-11119613 · Data updated 2026-11-12
This study is looking at how a gene called UBE3A affects brain development in people with Angelman Syndrome, using special mice to find out which proteins are impacted by this gene at different stages of growth, with the hope of discovering new ways to treat the condition.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Wisconsin-Madison NIH-funded |
| Lab location | 1 site (Madison, United States) |
| Project start | June 1, 2025 |
| Project end | May 31, 2027 |
| Funding year | 2025 |
| Award (this year) | $427,625 |
| NIH project number | 1R21NS142497-01 |
| Project ID | NIH-11119613 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with Angelman Syndrome or those carrying UBE3A mutations.
✕Less likely to help
Patients without Angelman Syndrome or UBE3A mutations may not benefit from this research.
What this research studies
This research investigates the role of the UBE3A gene in Angelman Syndrome, a severe neurodevelopmental disorder. By studying UBE3A mutant mice, the researchers aim to identify specific proteins that are affected by this gene mutation in different brain cell types and at various developmental stages. The approach involves analyzing how UBE3A influences protein ubiquitination, which is a process that regulates protein function and degradation. This could provide insights into the molecular mechanisms underlying Angelman Syndrome and help in developing targeted therapies.
Why it matters
Potential benefit: If successful, this research could lead to new treatments or interventions for individuals with Angelman Syndrome.
How similar studies have gone: While the specific approach of profiling the ubiquitome in UBE3A mutant mice is novel, similar studies have shown promise in understanding genetic disorders and their molecular mechanisms.
Where this research is happening
-
University of Wisconsin-Madison
Madison, United States Active
Researchers
- Principal investigator: Gao, Yu — University of Wisconsin-Madison
- Study coordinator: Gao, Yu
Related research
Other NIH-funded projects on the same topics.
-
BRAVE Innovation Center for Viral Resistance in Chickens
A center at UW–Madison aims to create chickens genetically resistant to avian viruses like H5N1 by identifying host genes involved in virus replication using genome-wide CRISPR screening.
-
Center to Fight Vector-Borne Diseases in the Midwest
A Midwest program brings researchers, public health teams, and vector-control groups together to prevent diseases spread by ticks and mosquitoes.
-
Globally useful predictor for cervical cancer treatment response
This project aims to develop a simple predictive signature to personalize treatment for locally advanced cervical cancer using easy tests and imaging.
-
Neutrophil development with stem cells to understand their behavior
Researchers are studying how neutrophils, a type of immune cell, develop from stem cells to better understand why they can help or harm in infections and inflammatory diseases.
-
WREN: Expanding Research Capacity in Rural Primary Care Clinics
A nationwide network in Wisconsin will strengthen rural primary care clinics to participate in real-world research and bring more clinical trials to communities.
-
Targeting early oral GVHD to improve mouth health after stem cell transplant
A study at UW–Madison will explore why some transplant patients develop painful oral GVHD and test ideas to prevent and lessen mouth-related problems.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.